Ocular histoplasmosis is a fungal infection that affects the eyes. It is caused by the fungus Histoplasma capsulatum, which is found in soil and bird droppings. Ocular histoplasmosis is a relatively rare condition, but it can cause significant vision loss if left untreated. In this article, we will take a closer look at the causes and treatment options for ocular histoplasmosis.
Ocular histoplasmosis (OH) is an infection of the eyes caused by the fungus Histoplasma capsulatum. The fungus is found in soil and bird droppings, and it is most commonly found in the Mississippi and Ohio River valleys. OH is a relatively rare condition, but it can cause significant vision loss if left untreated. OH is typically spread through airborne spores, which can be inhaled and then deposited in the lungs. The fungus can then spread to the eyes, where it can cause inflammation and damage to the retina and other parts of the eye. Symptoms of OH include blurred vision, floaters, and sensitivity to light. In some cases, OH can cause scarring of the retina, which can lead to permanent vision loss.
The primary cause of OH is exposure to the fungus Histoplasma capsulatum. This fungus is found in soil and bird droppings, and it is most commonly found in the Mississippi and Ohio River valleys. The fungus is spread through airborne spores, which can be inhaled and then deposited in the lungs. The fungus can then spread to the eyes, where it can cause inflammation and damage to the retina and other parts of the eye.
There are several factors that can increase the risk of developing OH. These include: • Living in or traveling to an area where the fungus is common • Exposure to bird droppings • Working in a profession that involves frequent exposure to soil or bird droppings • Having a weakened immune system
OH is typically diagnosed through a physical examination and a series of tests. The doctor may use a slit-lamp examination to look for signs of inflammation in the eyes. The doctor may also order a chest x-ray to check for signs of the fungus in the lungs. In some cases, a sample of fluid may be taken from the eye and examined under a microscope for signs of the fungus.
The primary treatment for OH is antifungal medication. The medication is typically taken orally for several weeks, and it can help to reduce the inflammation and clear up the infection. In some cases, a steroid may be prescribed to reduce inflammation in the eye. In severe cases of OH, surgery may be necessary to remove scar tissue from the retina. This can help to improve vision and prevent further damage. In some cases, laser treatment may be used to reduce the risk of vision loss.
Ocular histoplasmosis is a fungal infection of the eyes that can cause significant vision loss if left untreated. The primary cause of OH is exposure to the fungus Histoplasma capsulatum, which is found in soil and bird droppings. Risk factors for OH include living in or traveling to an area where the fungus is common, exposure to bird droppings, and having a weakened immune system. Treatment typically involves antifungal medication, and in some cases, surgery may be necessary to improve vision.
1.
Chemotherapy Boosts Survival for Older Patients With TNBC
2.
high response rate when using a bispecific antibody to treat R/R multiple myeloma.
3.
Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.
4.
Base-edited T-cell therapy offers additional hope for treating resistant leukemia.
5.
Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test
1.
Consensus Recommendations for Healthy Hematologic Aging
2.
Exploring the Role of Fecal Leukocytes in Intestinal Health
3.
Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization
4.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
5.
Clinical Pharmacology of Ferroptosis-Modulating Anticancer Pharmacotherapy
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
Current Scenario of Cancer- Q&A Session to Close the Gap
3.
Navigating the Complexities of Ph Negative ALL - Part XII
4.
Chemotherapy: What to Expect
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation